logo

For the Inventor, By the Inventor

Shanghai, China

Wentao Yang

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: The University of Texas System, Huawei Technologies Co., Limited, Shanghai Kelai Mechatronics Engineering Corp.. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wentao Yang. Retrieved from https://idiyas.com/inventor/wentao-yang-gvw1zmik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:

goldMedal2 out of 5,645 
 
The University of Texas System
 patents
silverMedal1 out of 30,003 
 
Huawei Technologies Co., Limited
 patents
bronzeMedal1 out of 1 
 
Shanghai Kelai Mechatronics Engineering Corp.
 patent
4. 1 out of 2 
 
Shanghai Okway Intelligent Equipment Co., Ltd
 patents
where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...
4 patents (USPTO):Explore Patents
1. 12527045 - Semiconductor device, and related module, circuit, and preparation method (2026-01-13),
2. 12479672 - Logistics palletizing system (2025-11-25),
3. 7709205 - 14-3-3 Zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer type (2010-05-04),
4. 7316907 - 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types (2008-01-08),

Title: Innovations and Contributions of Wentao Yang

Introduction

Wentao Yang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer research, particularly in understanding the role of 14-3-3 zeta in hyperproliferative diseases. His work has led to the development of innovative methods for determining prognosis and potential therapeutic targets in various cancer types.

Latest Patents

Wentao Yang holds 4 patents, with his latest patents focusing on the over-expression of 14-3-3 zeta as a poor prognosis factor in multiple cancer types. These patents disclose methods for determining prognosis in subjects with hyperproliferative diseases, including the expression and function of 14-3-3 zeta. Additionally, they outline methods for creating pharmaceutical agents that modulate apoptosis, which involves testing candidate substances for their ability to influence 14-3-3 zeta. The patents also detail the process of administering these pharmaceutical agents to treat subjects with hyperproliferative diseases, such as breast cancer.

Career Highlights

Wentao Yang is affiliated with the University of Texas System, where he continues to advance his research in cancer therapeutics. His innovative approaches have garnered attention in the scientific community, contributing to the understanding of cancer prognosis and treatment.

Collaborations

He has collaborated with notable colleagues, including Dihua Yu and Jun Yao, to further enhance the impact of his research in the field of cancer.

Conclusion

Wentao Yang's contributions to cancer research through his patents and collaborations highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in cancer treatment and prognosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…